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Abstract
Background: The magnitude of reproductive morbidity associated with sexually transmitted Chlamydia
trachomatis infection is enormous. Association of antibodies to chlamydial heat shock proteins (cHSP) 60
and 10 with various disease sequelae such as infertility or ectopic pregnancy has been reported. Cell-
mediated immunity is essential in resolution and in protection to Chlamydia as well as is involved in the
immunopathogenesis of chlamydial diseases. To date only peripheral cell mediated immune responses have
been evaluated for cHSP60. These studies suggest cHSPs as important factors involved in
immunopathological condition associated with infection. Hence study of specific cytokine responses of
mononuclear cells from the infectious site to cHSP60 and cHSP10 may elucidate their actual role in the
cause of immunopathogenesis and the disease outcome.
Methods: Female patients (n = 368) attending the gynecology out patient department of Safdarjung
hospital, New Delhi were enrolled for the study and were clinically characterized into two groups;
chlamydia positive fertile women (n = 63) and chlamydia positive infertile women (n = 70). Uninfected
healthy women with no infertility problem were enrolled as controls (n = 39). cHSP60 and cHSP10 specific
cytokine responses (Interferon (IFN)-gamma, Interleukin (IL)-10, Tumor Necrosis Factor (TNF)-alpha, IL-
13 and IL-4) were assessed by ELISA in stimulated cervical mononuclear cell supernatants.
Results: cHSP60 and cHSP10 stimulation results in significant increase in IFN-gamma (P = 0.006 and P =
0.04 respectively) and IL-10 levels (P = 0.04) in infertile group as compared to fertile group. A significant
cHSP60 specific increase in TNF-alpha levels (P = 0.0008) was observed in infertile group as compared to
fertile group. cHSP60 and cHSP10 specific IFN-gamma and IL-10 levels were significantly correlated (P <
0.0001, r = 0.54 and P = 0.004, r = 0.33 respectively) in infertile group.
Conclusion: Our results suggest that exposure to chlamydial heat shock proteins (cHSP60 and cHSP10)
could significantly affect mucosal immune function by increasing the release of IFN-gamma, IL-10 and TNF-
alpha by cervical mononuclear cells.
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Background
Sexually transmitted Chlamydia trachomatis infection is an
important public-health concern with major burden on
female reproductive tract [1]. Untreated chlamydial infec-
tion can lead to pelvic inflammatory disease (PID) in 10%
to 40% of affected women, which can result in infertility,
ectopic pregnancy and chronic pelvic pain [2].
Immune responses to C. trachomatis 60-kDa heat shock
protein (cHSP60) has been associated with the pathogen-
esis of C. trachomatis associated ectopic pregnancy and
tubal infertility [3,4]. A recent report from our lab suggests
that detection of anti-cHSP60 antibodies would help in
the early prognosis of immunopathological sequelae in C.
trachomatis  infected women [5]. The stress response in
Chlamydia reticulate bodies is characterized by cHSP60
induction and by reduction in major outer membrane
protein and lipopolysaccharide (LPS) levels, as shown in
an in vitro model of persistent infection [6,7]. This stress
response is believed to interrupt the normal progression
of reticulate bodies to infectious elementary bodies,
resulting in a longer-term persistent infection. Such per-
sistent infections may serve as antigenic reservoirs for
potentially immunopathogenic anti-cHSP immune sys-
tem responses [8]. The chlamydial 10-kDa heat shock pro-
tein (cHSP10) is genetically linked to cHSP60; the two
proteins bind to each other and prevent incorrect protein
folding and denaturation. Thus, the pathogen's ability to
survive stressful environmental conditions and persist in
the host is maximized by cHSP60-cHSP10 expression.
The development of infertility is reported due to
enhanced immune responses to C. trachomatis [9,10].
cHSP60 and cHSP10 antibodies seem to perform well in
predicting tubal factor infertility (TFI) [11-17]. Cell-medi-
ated immune responses to cHSP60 were demonstrated in
women with PID and TFI [18-23]. Thus, immunopatho-
genesis of TFI also involves cell-mediated mechanisms.
However, these studies were restricted to the peripheral
immune responses. A recent study suggests that mucosal
immune responses are better to predict pathogenesis as
cervical cells are the actual cells encountering the patho-
gen [24]. In the previous report from our lab cHSP60 and
cHSP10 specific proliferative responses were evaluated
and suggested the probable role of cHSPs in modulation
of mucosal immune responses [25]. Overall these studies
suggest cHSPs specific cell mediated immune responses
plays an important role in the immunopathogenesis asso-
ciated with chlamydial infection. Hence it might be possi-
ble that cytokines released by cervical mononuclear cells
that are in direct contact with the pathogens and with
cHSPs may play a crucial role in the modulation of
mucosal immune responses leading to pathogenesis.
Therefore, the objective of this study was to characterize
the cHSP60 and cHSP10 specific cytokine responses by
cervical mononuclear cells among groups of women rep-
resenting different clinical conditions, i.e. chlamydia pos-
itive fertile and infertile women for understanding their
role in modulation of immune responses at the site of
infection. The production of T helper type 1 (Th1)/Th2
cytokines was investigated as well as those of Tumor
Necrosis Factor-alpha (TNF-α) and Interleukin (IL)-10.
The role of Th1/Th2 responses in the genital tract during
Chlamydia infection is considered to be crucial for control-
ling the duration of infection and subsequent tubal
pathology. Indeed, Th1 cells produce Interferon-gamma
(IFN-γ) that promotes the destruction of Chlamydia [6]
but can also promote inflammatory damage and fibrosis
[26] whereas Th2 cells produce IL-4, IL-5, and IL-13
believed to be critical for defense against extracellular
pathogens. The production of TNF-α and IL-10 was exam-
ined because their levels have been reported to be high in
cervical secretions of C. trachomatis infected infertile
women [27].
Methods
Study population
A total of 368 patients attending the gynecology out
patient department, Safdarjung Hospital, New Delhi,
India for gynecological complaints (cervical discharge,
cervicitis and infertility) were enrolled in the study. The
study received approval by the hospital's ethics review
committee. Thirty-nine healthy age-matched controls
attending the family-planning department for birth-con-
trol measures and with no previous history of any sexually
transmitted disease (STD) were also enrolled. At recruit-
ment, a detailed clinical questionnaire was administered
to each patient for collecting information on reasons for
referral, gynecology history including menstruation,
symptoms of genital and urinary tract infection, obstetric
and medical histories. Patients with positive urine preg-
nancy test, recent antibiotic therapy and history of
recently treated sexually transmitted infection (STI) and
genital tuberculosis were excluded from the study.
Collection of samples
The vulva was examined for lesions and vaginal/cervical
discharge. The cervix was inspected for ulcers, warts, ect-
opy, erythema, discharge or any other abnormalities. After
cleaning the endocervix with a cotton swab (Hi Media,
Mumbai, India), endocervical swabs were collected from
patients for diagnosis of C. trachomatis and other STI path-
ogens.
The cervical canal was wiped clean, and a cytobrush was
placed within the endocervical canal so that cells from the
endocervical region and the zone between the endocervi-
cal and ectocervical regions (transformation zone) could
be obtained. The cytobrush was then held in a sterile cen-
trifuge tube containing phosphate buffered saline (PBS)Reproductive Biology and Endocrinology 2008, 6:20 http://www.rbej.com/content/6/1/20
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(pH 7.2) supplemented with 100 U penicillin/ml, 100 μg
streptomycin/ml, and 100 μg glutamine/ml. All cytobrush
samples had negative results for blood contamination.
Laboratory diagnosis
Spots were made on glass slides from cervical swab sam-
ples. These were stained with fluorescein isothiocyanate
conjugated monoclonal antibodies to C. trachomatis
major outer membrane protein (MOMP) using Chlamydia
trachomatis Direct Specimen Test kit (Microtrak, Syva Cor-
poration, Palo Alto, CA, USA) according to the manufac-
turer's instructions. A sample was considered to be
positive when at least 10 elementary bodies were detected.
Samples with greater than one and less than 10 EBs were
confirmed for positivity by polymerase chain reaction
(PCR) analysis using a primer specific for 200 base pair
(bp) plasmid of C. trachomatis [28]. Diagnosis for other
STD pathogens were done by culture for Neisseria gonor-
rhoeae, Mycoplasma hominis, Ureaplasma urealyticum and by
microscopy on gram stained smears for Candida sps., bac-
terial vaginosis, Trichomonas vaginalis as mentioned earlier
[27].
Cloning of cHSP60 and cHSP10
Full-length cHSP60 gene (GenBank accession no.
M58027) was amplified using unique primer set (Forward
primer – 5'-TCCCcccgggATGGTCGCTAAAAACATTAAA-3'
and Reverse primer 5'-ACGCgtcgacTTAATAGTCCATTC-
CTGCGCC-3' with restriction endonuclease sites, XmaI
and SalI respectively at 5'-end). Oligonucleotides used as
primers were synthesized by Microsynth, Balgach, Swit-
zerland. PCR products were initially cloned into pGEM-T
Easy vector (Promega, Madison, Wisconsin) and checked
for their correct reading frame by sequencing. The cloned
inserts were then excised by digestion with restriction
enzymes XmaI and SalI (New England Biolabs) and
ligated to the compatible sites of the expression vector
pQE-60 (Qiagen Inc., Chatsworth, California) in frame
with a His6 affinity tag-coding sequence at the 3' termi-
nus. The resulting plasmids were introduced into
Escherichia coli M15 cells and routinely grown in the pres-
ence of ampicillin (100 μg/ml) and kanamycin (25 μg/
ml) (Sigma).
Cloning of cHSP10 and large-scale expression and purifi-
cation of chlamydial recombinant proteins was per-
formed as mentioned earlier [29]. Proteins under native
conditions were purified by nickel chelate affinity chro-
matography (Qiagen Ni-NTA Superflow resin). The pro-
tein concentration was determined with the Bradford
assay (Sigma). We controlled for the non-specific effects
of LPS contamination by treating recombinant proteins
with polymyxin B (Sigma-Aldrich). Purified proteins were
subsequently characterized by SDS-PAGE and immunob-
lotting using monoclonal antibody against chlamydia
(Alexis Biochemicals, Lausen, Switzerland), separated
into aliquots and frozen at -80°C.
Purification and culture of cervical mononuclear cells
Cervical specimens were vortexed before the removal of
cytobrush. They were filtered through a 70-μm nylon cell
strainer (Becton Dickinson, San Diego, CA, USA) and cen-
trifuged at 200 g for 10 min and the cell pellet was resus-
pended in PBS. Mononuclear cells were separated by
Ficoll-Paque density gradient centrifugation. The mono-
nuclear cells were counted on haemocytometer and sam-
ples containing less than one million cells/ml were
excluded. The mononuclear cells were washed three times
with PBS and suspended in RPMI-1640 (Sigma-Aldrich)
containing 5% fetal calf serum (FCS) (PAA, Austria).
Briefly, endocervical mononuclear cells were cultured in
round-bottomed 96-well plates (5 × 104 cells/well) in a
total volume of 200 μl and subsequently stimulated with
cHSP60 (2 μg/ml) and cHSP10 (3 μg/ml) in triplicate.
Phytoheamagglutinin (PHA 2 μg/ml) (Sigma) was used as
a positive control mitogen in each experiment. Optimum
concentrations of antigen and mitogen were determined
in preliminary experiments as optimum concentrations
giving maximal proliferation post stimulation.
Antibody assays
Cervical washes of patients and controls were assayed for
presence of IgG antibodies to cHSP60 and cHSP10.
Briefly, the proteins were bound to the wells of a microti-
tre plate (1 μg/well) in carbonate buffer (14.2 mM
Na2CO3, 34.9 mM NaHCO3, 3.1 mM NaN3, pH 9.5) and
were incubated overnight at 4°C. After washing, wells
were blocked with PBS-0.5% bovine serum albumin
(BSA) at 37°C for 60 min; 100 μl of cervical washes were
then added, and after incubation at 37°C for 120 min 100
μl of 1: 10 000 dilution of peroxidase-conjugated goat
antibody to human IgG (Jackson Immunoresearch, Balti-
more, MD, USA) was added to each well. After further
incubation of 60 min at 37°C, the peroxidase substrate
tetramethylene benzidine was added. The reaction was
stopped with 0.5 M H2SO4 and the plates were read at 450
nm. Known positive and negative controls were always
assayed in parallel to test samples. A positive sample was
defined as one yielding an OD value that was at least 2
standard deviations (SD) above the mean value of known
negative samples as mentioned earlier [30].
Cytokine assays using ELISA
Quantification of IFN-γ, IL-10, TNF-α, IL-13 and IL-4 (ebi-
osciences, San Diego, CA, USA) in the supernatant of cer-
vical mononuclear cell cultures of samples after 72 h
stimulation with proteins was performed by commer-
cially available ELISA kits, in accordance with the manu-
facturer's instructions. The minimum detectable cytokine
concentrations for these assays were IFN-γ-(4 pg/ml), IL-Reproductive Biology and Endocrinology 2008, 6:20 http://www.rbej.com/content/6/1/20
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10-(2 pg/ml), TNF-α-(4 pg/ml), IL-13-(4 pg/ml) and IL-4-
(2 pg/ml).
Statistical analysis
Since the distributions in cytokine production were not
normal, differences between two groups were evaluated
using Mann-Whitney U test. A comparison between two
groups was made only when the Kruskal-Wallis test
yielded a statistically significant result. Categorical varia-
bles were compared using the χ2 test. Correlation was
tested with Spearman's correlation coefficient.
Results
Study population
Cervical C. trachomatis infection was diagnosed by direct
fluorescent assay (DFA)/PCR in 174 patients. Thirty-one
of these patients were found to have bacterial vaginosis, or
to be co-infected with either Candida sp., T. vaginalis, M.
hominis, U. urealyticum or N. gonorrhoeae in the cervix and
were thus excluded from the study. Ten Chlamydia positive
patients were excluded, as the count of mononuclear cells
in the cervical cells was less than 1 million cells/ml and
epithelial cells were present. Based on diagnosis the
women were divided into three groups. Group I (n = 39)
comprised of uninfected healthy controls with no infertil-
ity problem; Group II (n = 63) comprised of Chlamydia
positive women with no infertility problem; Group III (n
= 70) comprised of Chlamydia positive women with infer-
tility and who had laparoscopic or hysterosalpingo-
graphic evidence of tubal damage. Candidates were
considered infertile if they had regular unprotected inter-
course for at least 2 years without conception. The median
ages of women in each group were comparable (Table 1).
Detection of antibodies
ELISA results showed that the prevalence was significantly
higher for IgG antibodies to both cHSP60 (P = 0.04 & P <
0.0001) and cHSP10 (P = 0.03 & P < 0.0001) in Group II
and III respectively as compared to Group I. In Group III
the prevalence was significantly higher for IgG antibodies
to both cHSP60 and cHSP10 as compared to Group II (P
= 0.002 & P = 0.04 respectively) (Table 1). Correlation
between cHSP60 and cHSP10 specific IgG antibodies were
significant (P = 0.04, r = 0.26 & P < 0.0001, r = 0.6) in both
Group II and Group III respectively (Figure 1a &1b).
Cytokine production by stimulated cervical mononuclear 
cells
IFN-γ levels were significantly higher after stimulation
with both cHSP60 and cHSP10 in Group II (P = 0.04 &
0.02 respectively) and in Group III (P < 0.0001) as com-
pared to Group I. Significantly higher levels of IFN-γ were
observed after stimulation with both cHSP60 (P = 0.006)
and cHSP10 (P = 0.04) in Group III when compared with
Group II (Figure 2a). Similarly when IL-10 levels were
compared significant difference was observed after stimu-
lation with both cHSP60 and cHSP10 between Group II
(P = 0.03 & 0.04 respectively) and Group III (P = 0.0005
& 0.0007 respectively) as compared to Group I and IL-10
was significantly higher (P = 0.04) in Group III as com-
pared to Group II after cHSP60 and cHSP10 stimulation
(Figure 2b).
TNF-α levels were significantly higher after stimulation
with cHSP60 and cHSP10 (P < 0.0001 & P = 0.02 respec-
tively) in Group III as compared to Group I whereas there
was no significant difference (P = 0.07 & 0.25 respec-
tively) in Group II as compared to Group I. The TNF-α lev-
els were significantly higher (P = 0.0008) in Group III
when stimulated with cHSP60 as compared to Group II.
The TNF-α levels were higher although not significant (P
= 0.1) in Group III when stimulated with cHSP10 as com-
pared to Group II (Figure 2c).
IL-13 levels were low (close to the minimum detectable
cytokine concentrations) and no significant difference
was observed after stimulation with both cHSP60 and
cHSP10 in any group. There was no detectable IL-4 pro-
Table 1: Prevalance of cHSP60 and cHSP10 specific antibodies in study population
Groups Age Median (range) cHSP60-IgG cHSP10-IgG
Number (%)
Group I (n = 39) 25 (21–37) 3 (8) 2 (5)
Group II (n = 63) 27 (23–43) 15 (24)a 13 (21)b
Group III (n = 70) 29 (21–42) 35 (50)c,e 26 (37)d,f
(n) represents number of patients
aP = 0.04 as compared to Group I; bP = 0.03 as compared to Group I; cP < 0.0001 as compared to Group I; dP < 0.0001 as compared to Group I; eP 
= 0.002 as compared to Group II; fP = 0.04 as compared to Group II where,
Group I-Healthy women with no infertility problem
Group II-Chlamydia positive women with no infertility problem
Group III-Chlamydia positive women with infertility
Categorical variables were compared using the χ2 testReproductive Biology and Endocrinology 2008, 6:20 http://www.rbej.com/content/6/1/20
Page 5 of 10
(page number not for citation purposes)
duction in any culture supernatant after stimulation with
both cHSP60 and cHSP10 (Data not shown).
IFN-γ and IL-10 levels after stimulation with both cHSP60
and cHSP10 were significantly correlated in Group III (P
< 0.0001, r = 0.54 and P = 0.004, r = 0.33 respectively)
Median and range for cytokine concentration in all the
groups after cHSP60 and cHSP10 stimulation are men-
tioned in Table 2.
Median and range for cytokine concentration after PHA
stimulation were: IFN-γ [Group I: 22 (0–276), Group II:
87 (5–643), Group III: 120 (11–1049)]; IL-10: [Group I:
20 (0–366), Group II: 69 (7–823), Group III: 104 (5–
669)]; TNF-α [Group I: 17 (0–114), Group II: 72 (0–445),
Group III: 92 (0–382)]; IL-4 [Group I: 0 (0–2), Group II:
7 (0–25), Group III: 8 (0–18)]; IL-13 [Group I: 0.8 (0–5),
Group II: 24 (0–86), Group III: 18 (0–63)].
There was high standard error for cytokines as one or two
samples showed very high concentration of cytokines.
However, these high values did not affect the median
value as well as the significance of the results when data
was analyzed excluding these values.
Discussion
Disease stages developed upon infection with Chlamydia
are mediated by the immune responses. Immunity to C.
trachomatis HSP60 and HSP10 is associated more typically
Correlation of anti-cHSP60 and anti-cHSP10 IgG antibodies in cervical washes of patients Figure 1
Correlation of anti-cHSP60 and anti-cHSP10 IgG antibodies in cervical washes of patients. Scatter plot showing 
the correlation between anti-cHSP60 and anti-cHSP10 IgG antibodies among patients groups (a) Group II and (b) Group III. A 
significant correlation was observed in Group II as well as Group III where, Group II (n = 63) – Chlamydia positive women with 
no infertility problem. Group III (n = 70) – Chlamydia positive women with infertility. Correlation was tested with Spearman's 
correlation coefficient
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Cytokine concentrations after stimulation with cHSP60 and cHSP10 Figure 2
Cytokine concentrations after stimulation with cHSP60 and cHSP10. Box plot representing concentrations of (a) 
IFN-γ (b) IL-10 (c) TNF-α in supernatants of cervical mononuclear cells after stimulation with cHSP60 and cHSP10. A signifi-
cant increase in levels of IFN-γ, IL-10 and TNF-α was observed after stimulation with cHSP60 and increased IFN-γ and IL-10 
levels were observed after stimulation with cHSP10 in Group III as compared to Group I and Group II. The horizontal line in 
the middle of the box is the median value of the responses and the lower (upper) is the 25th (75th) percentile. I, II and III rep-
resent Group I, Group II and Group III respectively where, Group I (n = 39) – Healthy women with no infertility problem. 
Group II (n = 63) – Chlamydia positive women with no infertility problem. Group III (n = 70) – Chlamydia positive women with 
infertility. ns – Not significant. Mann-Whitney U-test was used for comparing two groups
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with the chronic upper genital tract infection than it is
with acute infection of the lower genital tract [15,31].
In the present study we detected higher cHSP60 and
cHSP10 specific IgG antibody responses in the cervical
washes of infertile group as compared to fertile group.
These results were consistent with the previous reports
where recurrent infection group showed high prevalence
of cHSP specific IgG and IgA antibodies [25]. We also
found a significant correlation of cHSP60 and cHSP10
IgG antibodies suggesting that co-expression of cHSP60
and cHSP10 occurs at the site of infection too. This obser-
vation again adds to the previous reports suggesting
cHSP10 is co-expressed with cHSP60 [32].
We also evaluated cHSP60 and cHSP10 specific cytokines
in cervical mononuclear cells and found IL-10 levels were
more prominent when stimulated with both cHSP60 and
cHSP10 in the infertility group as compared with other
groups. Our data is consistent with the previous studies in
which cHSP60 specific higher IL-10 levels in pheripheral
blood mononuclear cells (PBMCs) have been reported in
infertile women [21]. Cohen et al had recently demon-
strated that cHSP60 specific IL-10 production by PBMCs
act as a risk factor for C. trachomatis infection in humans
[22]. The enhanced levels of IL-10 may not be acting as
anti-inflammatory mediator and might be involved in
prolonging the infection by exerting immunostimulatory
effects [33]. Overall, these results allow hypothesizing the
role of IL-10 in fibrosis and tubal infertility. Indeed, IL-10
has been involved in fibrosis in several human diseases
[34-36] and an association of fibrosis with cHSP60 and
cHSP10 specific antibodies has been reported in infected
animals [37].
We also evaluated IFN-γ and TNF-α levels and higher lev-
els of both the cytokines were detected in infertility group
after stimulation with cHSP60 and cHSP10. IFN-γ produc-
tion has been identified as one of the main factors in pro-
tective immunity [38] and is also important in the
development of chronic chlamydial infection [8]. IFN-γ
delays the developmental cycle of Chlamydia so that
chlamydial reticulate bodies persist longer, which might
result in persistent unapparent infection and also, play a
role in immunopathogenesis by promoting inflammatory
damage and fibrosis [26]. In addition, increased levels of
IFN-γ have been reported in the endocervical secretions of
C. trachomatis positive infertile women [27]. TNF-α which
displays antichlamydial properties [39], is also known to
play an important role in the initiation of inflammatory
response. In the mouse genital tract, infertility associated
with endometriosis has been shown to be related to the
production of TNF-α [40]. In human, both IFN-γ and
TNF-α have been reported to be associated with infertility
[41-43]. Proinflammatory cytokines are also known to
drive the lipid peroxidation of the spermatozoa plasma
membrane to levels that can affect the sperm fertility
capacity [44]. In addition TNF-α and IFN-γ have effects on
sperm motility, viability, membrane integrity and lateral
head displacement, suggesting poor fertilizing potential
of human spermatozoa during inflammatory conditions
[45]. Previous evidence suggests that the concurrent
immunization with cHSP60 switches the cytokine pro-
duction of self HSP60 responding T cells to dominant pro-
duction of proinflammatory IFN-γ [46] showing that
chlamydial HSP60 can break the tolerance of autoreactive
cell reactions and lead them to participate in the inflam-
matory reactions during chlamydial disease. Hence from
the present study higher levels of both IFN-γ and TNF-α by
cHSPs in infertility group may suggest their involvement
in the immunopathological condition associated with the
infertility.
In our study, IL-4 was undetectable and IL-13 levels were
not significantly different in any group in contrast to pre-
vious report in which cHSP60 specific IL-13 in PBMCs has
been reported to be associated with the protective
response [22]. It may suggest that cHSP specific Th2
cytokines (IL-4 and IL-13) does not play any role in
pathogenesis related to chlamydial infection.
Table 2: Concentration (pg/ml) of cHSP60 and cHSP10 specific cytokines in different groups.
Groups IFN-γ IL-10 TNF-α
cHSP60 cHSP10 cHSP60 cHSP10 cHSP60 cHSP10
Median (range) in pg/ml
Group I (n = 39) 11 (0–115) 8 (0–193) 15 (0–289) 8 (0–174) 6 (0–121) 14 (0–128)
Group II (n = 63) 28 (0–508) 24 (0–480) 27 (0–278) 26 (0–671) 14 (0–199) 19 (0–289)
Group III (n = 70) 90 (0–743) 67 (0–516) 63 (0–973) 52 (0–758) 77 (0–694) 45 (0–566)
(n) represents number of patients
Group I-Healthy women with no infertility problem
Group II-Chlamydia positive women with no infertility problem
Group III-Chlamydia positive women with infertilityReproductive Biology and Endocrinology 2008, 6:20 http://www.rbej.com/content/6/1/20
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In our results high levels of IL-10 may not suggest a Th2
response as studies showed that it is secreted by Th1 and
Th2 cells as well as other cells [47,48]. Further it has been
shown that in many chronic infections in human and
experimental animals, CD4+ T cells can produce high lev-
els of both IL-10 and IFN-γ [49]. Hence the production of
high levels of both the cytokines, IL-10 and IFN-γ in the
absence of significant levels of other Th2 cytokines, sug-
gests that the cells secreting IL-10 are not Th2 cells but
other cells.
Previous studies, suggested that immune sensitization to
HSPs probably require prolonged exposure of them at ele-
vated concentrations [50]. As for cHSP60, there have been
reports that during repeated and severe C. trachomatis
infection there is enhanced recognition of cHSP60 by cir-
culating lymphocytes [18,51] and it has been shown that
PBMCs from women with tubal factor infertility
responded more frequently to cHSP60 antigen [21].
Hence the differential responses to cHSPs in chlamydia
infected fertile and infertile women would be due to pro-
longed exposure to cHSPs in infertile cases.
We also did the correlation analysis of different cytokines
produced against cHSP60 and cHSP10 and observed a
positive correlation for IL-10 and IFN-γ levels in infertility
group suggesting similar role of cHSP10 in pathology
associated with the infertility as cHSP60. There are no
studies to date on cHSP10 specific cell mediated immune
responses and our data suggests that the cHSP10 specific
immune responses may have crucial role in the immun-
opathological condition associated with the infertility.
Reports on the immunogenicity of HSP10 antigens from
other microbial pathogens suggest that the HSP10 family
of proteins are capable of eliciting chronic inflammation
and delayed hypersensitivity. In particular, HSP10 homo-
logues of Mycobacterium leprae and Mycobacterium tubercu-
losis  have been shown to stimulate T-cell responses
[52,53].
Overall our results suggest that exposure to the chlamydial
heat shock proteins could significantly affect mucosal
immune function by modifying the release of cytokines
leading to severe immunopathological conditions related
to infertility.
Conclusion
The intent of the study provides some perspective on the
ways in which cHSPs may contribute to the disease proc-
ess associated with chlamydial infections. From the
present study it can be suggested that the enhanced HSP
expression leads to antigen specific increase in IFN-γ, IL-
10 and TNF-α at the site of infection by cervical mononu-
clear cells suggesting cHSPs may consequently contribute
to the immunopathogenesis associated with the infertil-
ity. This study also points out that further research is war-
ranted to more precisely define the potential contribution
of cHSPl0 and other conserved chlamydial antigens to the
immunopathologic process associated with chlamydial
infection.
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